共 50 条
- [21] The role of nuclear medicine in the evaluation of neuropsychiatric systemic lupus erythematosus: comment on the article by Sibbitt et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1904 - 1904
- [22] Epigenetic considerations in investigating the cause of systemic lupus erythematosus: comment on the article by Chagnon et al ARTHRITIS AND RHEUMATISM, 2007, 56 (03): : 1035 - 1035
- [24] Characterization of flares in patients with systemic lupus erythematosus: comment on the article by Ho et al - Reply ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 582 - 582
- [26] Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: comment on the article by Efthimiou et al ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 309 - 309
- [27] APRIL in systemic lupus erythematosus: essential or dispensable? Comment on the article by Jacob et al Reply ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2053 - 2054
- [28] Mycophenolate mofetil in the treatment of systemic lupus erythematosus: comment on the article by Hervier et al Reply ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3489 - 3490
- [29] Is cigarette smoking a risk factor for systemic lupus erythematosus?: Comment on the article by Costenbader et al ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1340 - 1341
- [30] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158